AIDS 2016

Protocol

Title

Authors

Presentation Type, Time

P1110

Raltegravir (RAL) Pharmacokinetics (PK) and Safety in HIV-1 Exposed Neonates at High Risk of Infection (IMPAACT P1110)

Clarke DF, Acosta EP, Chain A, Cababasay M, Wang J, Calabrese K, Spector SA, Bryson YJ, Teppler H, Popson S, Graham B, Smith B, Hazra R, Homony B, Murray R, and Mirochnick M and the P1110 Protocol Team

Oral presentation,
12:15 am

PROMISE 1077BF

Comparing Maternal Triple Antiretrovirals (mART) and Infant Nevirapine (iNVP) Prophylaxis for the Prevention of Mother-to-Child Transmission (MTCT) of HIV during Breastfeeding (BF)

Taha T, Flynn P, Cababasay M, Fowler MG, Mofenson L, Owor M, Fiscus S, Stranix-Chibanda L, Coutsoudis A, Gnanshanmugam D, Chakhtoura N, McCarthy K, Kawalazira R, Mukuzunga C, Moodley D, and the PROMISE Study Team

Oral presentation,
11:15 am

PROMISE P1084s

Impact of tenofovir-containing triple antiretroviral therapy (ART) on bone mineral density in HIV-infected breastfeeding women in sub-Saharan Africa

Stranix-Chibanda L, Tierney C, Marr C, George K, Sebikari D, Dadabhai S, Zanga A, Mukwasi C, Vhembo T, Fan B, Browning R, Mofenson L, Shepherd J, Fowler MG, Siberry G

Oral presentation,
11:45 am

P1104s

Neuropsychological performance in African children with HIV enrolled in a multi-site anti-retroviral clinical trial is poorer than non-infected children at those study sites

Boivin M, Chernoff M, Zimmer B, Laughton B, Joyce C, McCarthy K, Brouwers P, Jean-Philippe P, Lee S, Coetzee J, Violari A, Cotton M, Palumbo P, and the P1104s Study Team

Oral presentation,
2:30 pm

PROMISE 1077BF, 1077FF, 1077HS

Low acceptance of early antiretrovial therapy (ART) among post-partum women in 14 countries across the globe

Stranix-Chibanda L, Brummel S, Coletti A, Pilotto J, Nematadzira T, Kamateeka M, Masheto G, Chamanga R, Maluwa M, Hanley S, Browning R, Chakhtoura N, Basar M, Currier J, Fowler MG

Poster

PROMISE 1077BF, P1084s

Impact of maternal triple antiretroviral therapy (ART) versus infant nevirapine prophylaxis on somatic growth of breastfeeding infants in the PROMISE trial

Stranix-Chibanda L, Tierney C, Marr C, George K, Musoke P, Chipoka G, Mallewa M, NaidAoo M, Nematadzira T, Kusakara B, Violari A, Mbengeranwa T, Browning R, Fowler MG, Siberry G, PROMISE 1077BF Study Team

Poster

P1025

Pregnancy and Birth Outcomes of Perinatally HIV-infected Women in the U.S.: A Combined Analysis of the PHACS SMARTT study and IMPAACT P1025 Protocol

Jao J, Kacanek D, Williams P, Geffner M, Livingston E, Sperling R, Patel K, Bardeguez A, Burchett S, Chakhtoura N, Scott G, Van Dyke R, and Abrams EJ for the Pediatric HIV/AIDS Cohort Study (PHACS) and the International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) P1025 Protocol

Poster

PROMISE

Neurodevelopment of Ugandan and Malawian PROMISE HIV unexposed uninfected children at 12 and 24 months of age

Boivin MJ, Maliwichi-Senganimalunje L, Nyakato M, Sikorskii A, Wambuzi Ogwang A, Kawalazira R, Mallewa M, Familiar-Lopez I, Ruiseñor-Escudero H, Aizire J, Taha T, Fowler MG

Poster

PROMISE

Growth at 12 and 24 months-of-age among PROMISE (HIV and ARV) exposed uninfected versus unexposed children in Malawi and Uganda

Aizire J, Sikorskii A, Wambuzi Ogwang L, Mallewa M, Familiar-Lopez I, Mutebe A, Dadabhai S, Taha T, Boivin MJ, Fowler MG for the PROMISE Neurodev Study Team

Poster

P1113

IMPAACT P1113/Aeras C-015-404: Phase I/II Study of H4:IC31 in BCG-Primed Infants

Nachman S, Andersen-Nissen E, Fiore-Gartland A, Hural J, McElrath MJ, Shi S, Eisner J, Coletti A, Dintwe O, DiazGranados D, Jean-Philippe P, Cotton M, Fairlie L, Violari A, and the P1113 study team

Poster

PHOENIx 2003

A5300/I2003: Feasibility of identifying, recruiting, and characterizing adult MDR TB index cases and their adult and child household contacts on four continents

Swindells S, Kim S, Gupta A, Hesseling A, Shah S, Johnson D, Harrington M, Suryavanshi N, Sanchez J, Dawson R, Naini L, Jones L, Hughes M, Churchyard G

Poster

PROMISE 1077BF

Comparing Maternal Triple Antiretrovirals (mART) and Infant Nevirapine (iNVP) Prophylaxis for the Prevention of Mother-to-Child Transmission (MTCT) of HIV during Breastfeeding (BF)

Taha T, Flynn P, Cababasay M, Fowler MG, Mofenson L, Owor M, Shapiro D, Fiscus S, Stranix-Chibanda L, Coutsoudis A, Gnanshanmugam D, Chakhtoura N, McCarthy K, Mukuzunga C, Kawalazira R, Moodley D, Nematadzira T, Kusakara B, Bhosale R, Vhembo T, Bobat R, Mmaga B, Masenya M, Nyati M, Theron G, Mulenga HB, PROMISE Study Team

Poster

P1104s

Neuropsychological performance of HIV-infected and uninfected African children

Boivin M, Chernoff M, Laughton B, McCarthy K, Barlow-Mosha L, Brouwers P, Jean-Philippe P, Violari A, Cotton M, Palumbo P, and the P1104s Study Team

Poster

P1025

Pregnancy and Birth Outcomes of Perinatally HIV-infected Women in the U.S.: A Combined Analysis of the PHACS SMARTT study and IMPAACT P1025 Protocol

Jao J, Kacanek D, Williams P, Geffner M, Livingston E, Sperling R, Patel K, Bardeguez A, Burchett S, Chakhtoura N, Scott G, Van Dyke R, Abrams EJ, for the Pediatric HIV/AIDS Cohort Study (PHACS) and the International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) P1025 Protocol

Oral presentation,
11:00 am – 12:30 pm

P1115

Establishing a Treatment Dose of Nevirapine (NVP) for Full-term Neonates with Perinatal HIV Infection: IMPAACT P1115

Chadwick EG, Qin M, Bryson Y, Mirochnick M, Ruel T, Zadzilka A, Coletti A, Zimmer B, Tierney C, Persaud D Cotton M, Jean-Philippe P, Hazra R, Jennings C and Capparelli EV for the IMPAACT P1115 Team

Poster

PROMISE 1077HS

Randomized Trial of Stopping or Continuing ART among Postpartum Women with Pre-ART CD4 > 400 cells/mm3 (IMPAACT PROMISE 1077HS)

Currier J, Britto P, Hoffman R, Brummel S, Masheto G, Joao E, Santos B, Aurpibul L, Losso M, Pierre MF, Weinberg A, Chakhtoura N, Browning N, Coletti A, Shapiro D, Pilotto J, PROMISE 1077HS Team

Oral presentation,
11:00 am – 12:30 pm

PROMISE 1077BF, 1077FF, 1077HS

Low acceptance of early antiretroviral therapy (ART) among post-partum women enrolled in the IMPAACT PROMISE studies across the globe

Stranix-Chibanda L, Brummel S, Angelidou K, Tierney C, Coletti A, McCarthy K, Pilotto J, Mutambanengwe M, Chanaiwa V, Mhembere T, Kamateeka M, Masheto G, Chamanga R, Maluwa M, Hanley S, Joao E, Theron G, Chandawale A, Nyathi M, Santos B, Aurpibul L, Mubiana-Mbewe M, Oliveira R, Basar M, Chakhtoura N, Browning R, Currier J, Fowler MG, PROMISE study team

Oral presentation,
11:00 am – 12:30 pm

PROMISE

Neurodevelopment of Ugandan and Malawian PROMISE HIV unexposed uninfected children

Boivin MJ, Sikorskii A, Aizire J, Maliwichi- Senganimalunje L, Wambuzi Ogwang L, Nyakato M, Mallewa M, Familiar-Lopez I, Ruiseñor-Escudero H, Taha T, Fowler MG

Oral poster discussion,
1:00 pm – 2:00 pm